Quest Diagnostics To Acquire PathAI Diagnostics To Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements With PathAI

by | May 6, 2024 | FEATURED, HEADLINE, Stocks

 SECAUCUS, N.J. and BOSTON, May 6, 2024 /3BL/ – Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global … 

 

Read More 

FEATURED